Apellis Pharmaceuticals · 8 hours ago
Sr. Manager, Market Access Marketing
Waltham, MA
Full-time
Hybrid
Senior Level
$146K/yr - $219K/yr
5+ years expApellis Pharmaceuticals is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. The Senior Manager will play an integral role on the VAP marketing team, supporting the design and implementation of payer and GPO marketing tactics that deliver on the Syfovre and Empaveli US market access strategy.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Hiring Manager
Kelly Bollenbach
Responsibilities
Lead the development of brand-specific payer and GPO marketing resources, including product value propositions, core customer presentations, targeted messaging, and other proactive communications and tools to support brand launch/growth
Partner closely with cross-functional business partners and field teams (Brand Marketing, HEOR, Medical, Business Intelligence) to execute on payer and GPO marketing strategies
Manage agencies and other vendors in the development of marketing materials and tactics, tracking expiry of materials, initiating renewals of resources as needed, and managing agency budgets
Support both the payer field team and strategic accounts field team in their customer interactions
Engage directly with field-based teams on Field Input Team (FIT) calls, gathering customer insights/feedback and synthesizing ideas into relevant marketing resources to support customer interactions
Proactively identify any gaps in field educational resources and work closely with the marketing agency and field teams on solutions to bridge that gap
Partner with field leads in the development of QBR templates and other presentations for reporting on quarterly updates internally
Partner with Market Access teams, such as Pricing & Contracting, as needed to support key business activities
Identify challenges and opportunities within the payer and GPO segments by working across functions to develop effective solutions that support the overall Brand Plan
Work closely with the HEOR team to connect RWE & other evidence generation efforts with value messaging and resources for access customers
Ensure VAP marketing tactics are compliant and implemented in a timely fashion by working in partnership with the Medical, Legal, and Regulatory review team (Promotional Review Committee)
Roll out new tactics in partnership with the Training team and field-based teams or via POA/launch meetings
Support and help lead the development and implementation of the annual brand planning and functional planning processes
Support the Market Access strategy team with other projects as needed depending on business requirements
Qualification
Required
At least 5 years of Pharma/Biotech experience with at least 3 years in Payer or Market Access Marketing
Must have the ability to act as a cross-functional leader to drive execution of access strategies by working closely with Field, Pricing & Contracting, HEOR, and Medical teams
Able to understand clinical data and work with Legal/Regulatory teams to create marketing materials
High level of integrity with strong communication and interpersonal skills
A strong team player that acts proactively across the US market access, US commercial brand, and global market access organizations
Strong understanding of US payer landscape including payer and channel dynamics, account management, reimbursement/distribution
Proven ability to lead and manage complex enterprise-wide strategic initiatives
Strong project management skills
Strong executive written and verbal communication skills
Bachelor's Degree
Preferred
Ophthalmology/retina, hematology/oncology, and nephrology experience preferred
Benefits
401(k) plan with company match
Inclusive family building benefits
Flexible time off
Summer and winter shutdowns
Paid family leave
Disability and life insurance
Company
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$919.6MKey Investors
Swedish Orphan BiovitrumSixth StreetNorthern Star Partners
2025-06-01Post Ipo Debt· $275M
2024-05-14Post Ipo Debt· $475M
2022-04-14Post Ipo Equity· $1.07M
Leadership Team
Cedric Francois
Co-Founder and CEO
Caroline Baumal
Chief Medical Officer
Recent News
2026-01-18
Investor's Business Daily
2026-01-13
Company data provided by crunchbase